Standout Papers

Laminin–a glycoprotein from basement membranes. 1979 2026 1994 2010 2.0k
  1. Laminin–a glycoprotein from basement membranes. (1979)
    Rupert Timpl, H. Rohde et al. Journal of Biological Chemistry
  2. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease (2010)
    John R. Hurst, Jørgen Vestbo et al. New England Journal of Medicine
  3. A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation (1999)
    Douglas E. Jorenby, Scott J. Leischow et al. New England Journal of Medicine
  4. Chronic Obstructive Pulmonary Disease Phenotypes (2010)
    MeiLan K. Han, Àlvar Agustí et al. American Journal of Respiratory and Critical Care Medicine
  5. Changes in Forced Expiratory Volume in 1 Second over Time in COPD (2011)
    Jørgen Vestbo, Lisa Edwards et al. New England Journal of Medicine
  6. Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012)
    Àlvar Agustí, Lisa Edwards et al. PLoS ONE
  7. Interstitial Lung Diseases of Unknown Cause (1984)
    Ronald G. Crystal, Peter B. Bitterman et al. New England Journal of Medicine
  8. Enzyme-linked immunoassay (ELISA) for connective tissue components (1980)
    Stephen I. Rennard, R A Berg et al. Analytical Biochemistry
  9. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. (1980)
    John R. Hassell, Pamela Gehron Robey et al. Proceedings of the National Academy of Sciences
  10. A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci (2009)
    Sreekumar Pillai, Dongliang Ge et al. PLoS Genetics
  11. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function (2016)
    Prescott G. Woodruff, R. Graham Barr et al. New England Journal of Medicine
  12. Interstitial Lung Diseases of Unknown Cause (1984)
    Ronald G. Crystal, Peter B. Bitterman et al. New England Journal of Medicine
  13. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials (2018)
    Mona Bafadhel, Stefan Peterson et al. The Lancet Respiratory Medicine

Immediate Impact

4 by Nobel laureates 9 from Science/Nature 61 standout
Sub-graph 1 of 16

Citing Papers

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
Reversed-engineered human alveolar lung-on-a-chip model
2021 Standout
19 intermediate papers

Works of Stephen I. Rennard being referenced

Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook
2023
Early chronic obstructive pulmonary disease: definition, assessment, and prevention
2015
and 10 more

Author Peers

Author Last Decade Papers Cites
Stephen I. Rennard 19767 11938 6743 537 34.5k
Dirkje S. Postma 18310 16257 3928 564 30.4k
Serpil C. Erzurum 9953 9963 5652 292 24.4k
Klaus F. Rabe 24923 17533 4541 500 36.2k
Ian M. Adcock 12191 12845 11339 592 35.3k
Joe G. N. Garcia 7103 5009 15067 556 30.2k
Marc Humbert 46488 12182 6897 917 58.9k
Jay A. Nadel 9474 9233 4339 373 21.0k
Werner Seeger 28236 6949 11385 1.1k 50.0k
Peter D. Paré 16316 10563 2754 369 23.1k
Nikolaos G. Papadopoulos 4614 5251 7039 606 23.6k

All Works

Loading papers...

Rankless by CCL
2026